Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Zoll Medical Corp. CEO Richard Packer says a change in the way Medicare pays for LifeVest would impact only 8 percent of the company’s total sales, calls the device critical for helping cardiologists stay within ICD guidelines.
The $10 million deal for Calypso Medical Technologies by Varian Medical Systems leaves a lot to be desired for Calypso’s legacy investors – namely, about $140 million.
It’s been a tough stretch in the courtroom for Johnson & Johnson’s Cordis Corp. The health care giant’s stent-making unit lost its bid for a new trial in the $482 million patent infringement lawsuit it lost to stent pioneer Dr. Bruce Saffran.